1. Home
  2. VUZI vs GNFT Comparison

VUZI vs GNFT Comparison

Compare VUZI & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VUZI
  • GNFT
  • Stock Information
  • Founded
  • VUZI 1997
  • GNFT 1999
  • Country
  • VUZI United States
  • GNFT France
  • Employees
  • VUZI N/A
  • GNFT N/A
  • Industry
  • VUZI Industrial Machinery/Components
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VUZI Technology
  • GNFT Health Care
  • Exchange
  • VUZI Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • VUZI 207.4M
  • GNFT 186.3M
  • IPO Year
  • VUZI N/A
  • GNFT 2019
  • Fundamental
  • Price
  • VUZI $2.00
  • GNFT $3.73
  • Analyst Decision
  • VUZI Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • VUZI 1
  • GNFT 1
  • Target Price
  • VUZI $2.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • VUZI 1.4M
  • GNFT 3.8K
  • Earning Date
  • VUZI 08-14-2025
  • GNFT 09-18-2025
  • Dividend Yield
  • VUZI N/A
  • GNFT N/A
  • EPS Growth
  • VUZI N/A
  • GNFT N/A
  • EPS
  • VUZI N/A
  • GNFT 0.03
  • Revenue
  • VUZI $5,331,630.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • VUZI $45.35
  • GNFT $5.15
  • Revenue Next Year
  • VUZI $54.01
  • GNFT N/A
  • P/E Ratio
  • VUZI N/A
  • GNFT $123.99
  • Revenue Growth
  • VUZI N/A
  • GNFT 105.01
  • 52 Week Low
  • VUZI $0.83
  • GNFT $2.55
  • 52 Week High
  • VUZI $5.79
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • VUZI 37.73
  • GNFT 43.60
  • Support Level
  • VUZI $1.88
  • GNFT $3.71
  • Resistance Level
  • VUZI $2.34
  • GNFT $4.12
  • Average True Range (ATR)
  • VUZI 0.14
  • GNFT 0.14
  • MACD
  • VUZI 0.00
  • GNFT -0.02
  • Stochastic Oscillator
  • VUZI 21.05
  • GNFT 10.90

About VUZI Vuzix Corporation

Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: